This study aimed to determine whether an MPC algorithm-based artificial pancreas system might be more effective than conventional insulin therapy in terms of hypoglycemia risk and maintaining glucose levels within the target range in outpatients with T1D. The gene discussed is INS; the disease is Hypoglycemia.